Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Renal Insufficiency, Chronic

• SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
• Efficacy and Safety of Lorundrostat Alone, and in Combination With Dapagliflozin in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
• Acute Equol Supplementation and Vascular Function in Women With and Without CKD
• Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients
• Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
• Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
• Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)
• The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
• GLUcose Transport and REnalPROtection in Chronic Kidney Disease
• A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
• Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients
• A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
• A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
• Bone in CKD Alkali Response (BICARb Pilot Trial)
• A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
• Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients
• Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
• A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Ch
• Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
• Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
• Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease
• Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD)
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
• A Study to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants
• Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease
• Safety of and Tolerability to a Sodium-free Peritoneal Dialysis Solution
• A Study of Renal Microvessel Imaging for Chronic Kidney Disease
• A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients
• Perioperative Nitric Oxide Prevents Acute Kidney Injury in Cardiac Surgery Patients With Chronic Kidney Disease
• Gabapentin Versus Loratadine in Uremic Pruritus
• A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients
• ARTEMIS: A Phase 3 Study of Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
• Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia
• The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol
• Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function
• Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients
• Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
• Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients
• Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
• Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD Children
• Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study.
• A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus
• Denosumab Treatment in CKD Patients at High Risk of Fracture
• Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia
• A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
• Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
• A Study of MK-2060 in Participants With Chronic Kidney Disease (MK-2060-011)
• Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects
• Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients
• Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
• Effect of Allopurinol on Markers of Mineral and Bone Metabolism
• Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients
• A Study to Assess the Effects of Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria
• A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation
• Oral Iron Supplementation for Patients With Chronic Kidney Disease
• Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
• Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease
• A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
• A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal
• A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).
• Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
• A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single a
• Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
• The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial
• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney
• A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease
• Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects
• Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of US-APR2020 In Subjects With CKD IV Completing The US-APR2020-01 Study
• Evaluate the Effect and Safety of Pu Yang Wan Wu Tang and Western Medicine on Chronic Kidney Disease
• A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation
• The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
• Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression
• Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
• Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients With Chronic Kidney Disease
• CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus and Not on Dialysis
• Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
• A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus and Not on Dialysis
• Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum
• Empagliflozin in Acute Heart Failure
• A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects
• Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease
• Enhancing the Natriuretic Peptide System in HFpEF
• A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
• Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
• Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
• A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes
• Testosterone Treatment in Men With Chronic Kidney Disease
• Sleep Disorders in Chronic Kidney Disease Patients
• Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease
• Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients
• Outcome of Glargine Insulin in Renal Impairment Patients With Diabetic Ketoacidosis
• A Study to Test BI 764198 in People With a Type of Kidney Disease Called Primary Focal Segmental Glomerulosclerosis
• Dapagliflozin and Renal Surrogate Outcomes in Advanced Chronic Kidney Disease
• A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Childr
• A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease
• SGLT2 Inhibition in Hemodialysis
• Sit Less, Interact and Move More (SLIMM) 2 Study
• Diuretics and Volume Overload in Early CKD
• Study of Sulphoraphane in Chronic Kidney Disease
• Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
• A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients With Chronic Kidney Disease-Associated Pruritus
• Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)
• PRevEnting FracturEs in Renal Disease - 1
• A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney Function
• Study for Desensitization of Chronic Kidney Disease Adult Patients in Need of a Kidney Transplant Who Are Highly Sensitized to Human Leukocyte Antigen
• Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
• Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents
• Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease
• To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Severe Pruritus
• A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
• A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease
• the Accuracy and Safety of Renal Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle
• A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients
• Effect of Dietary Magnesium Supplementation vs. Dapagliflozin in Patients With Diabetic Kidney Disease (DKD)
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
• STUDY OF RENAL AUTOLOGOUS CELL THERAPY (REACT) IN SUBJECTS WITH TYPE 1 or 2 DIABETES AND CHRONIC KIDNEY DISEASE (REGEN-007)
• An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Parti
• Lokelma for RAAS Maximisation in CKD & Heart Failure.
• A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism
• Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants
• A Phase 1/2 Study Evaluating the Safety and Efficacy of CLBS201 in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
• Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease
• Randomized Trial of Veverimer on Muscle Mitochondrial Energetics and Physical Endurance in Persons With CKD
• Crossover Clinical Trial, Randomized, Double Blind, Placebo Controlled Trial
• Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe CKD
• Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney Disease
• Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease
• Vascular Impact of Dapagliflozin in CKD Patients (DAPAVASC)
• HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia
• Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD
• Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction
• Renal Tubular Injury and Transplant Outcomes in Cardiac Recipients Converting From IR Tacrolimus to XR Tacrolimus
• N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease
• Clinical Trial To Evaluate Safety And Efficacy Of US-APR2020 In Subjects With Chronic Kidney Disease Stage IV
• A Study to Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution
• A Phase 1 Study of SSS17 in Healthy Subjects.
• Curcuminoids and Contrast-induced Acute Kidney Injury
• A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease
• Stem Cell Therapy for Chronic Kidney Disease
• A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
• Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation
• Study of the Influence of Liver Function on Blood Concentrations of Runcaciguat in Participants With Different Degrees of Liver Impairment
• Dapagliflozin in Non-diabetic Stage IV CKD
• Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
• Ferric Citrate and Chronic Kidney Disease in Children
• A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Chronic Kidney Disease Who do Not Have Diabetes
• Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy Volunteers
• Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial)
• Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
• Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)
• Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis
• Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)
• Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects
• Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Subjects With Chronic Kidney Disease (CKD), Stages 3 and 4
• A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN)
• Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.
• Berinert (C1INH) vs Placebo for DGF/IRI
• Desidustat in the Treatment of Chemotherapy Induced Anemia
• A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.
• Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia
• A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)
• Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
• Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.
• Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease
• Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis
• Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD
• Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD
• Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease
• Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease
• A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol
• Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia
• PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD
• Efficacy of Diuretics in Kidney Disease
• Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers
• Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease
• Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
• Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
• A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
• QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir
• Evolocumab In Advanced Chronic Kidney Disease Trial
• Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressur
• Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
• A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
• Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.
• Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
• Combination of Novel Therapies for CKD Comorbid Depression
• Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients
• ASPIrin in Reducing Events in Dialysis ( ASPIRED )
• A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease
• African American Study of Kidney Disease and Hypertension
• The Modification of Diet in Renal Disease Study
• Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis
• A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease
• A Study of SSS17 in Healthy Subjects
• Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous
• Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
• Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis
• Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease
• A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart
• REGROUP: Renohemodynamic Effects empaGliflozin in vaRiOUs Populations
• A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
• The Use of Midazolam and Remifentanil During Dialysis Access Procedures
• Effect of SGLT2 Inhibition on OCT-A Parameters in Diabetic CKD
• Desidustat in the Treatment of Anemia in CKD on Dialysis Patients
• Food Effect Study of DDO-3055 Tablets in Healthy Subjects
• Diuretics and Volume Overload in Early CKD
• A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body
• A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
• A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient
• SGLT2 Inhibitors in Glomerular Hyperfiltration
• Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions
• Curcumin and Exercise in Chronic Kidney Disease
• Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics
• Multiple Doses of DM199 in Patients With Chronic Kidney Disease
• A Study With SnPP, in Healthy Volunteers and Subjects With Stage 3-4 Chronic Kidney Disease
• A Study With Iron Sucrose in Healthy Volunteers and Chronic Kidney Disease Stage 3-4 Subjects
• Effects of Green Propolis Extract (EPP-AF) on Inflammation in Hemodialysis Patients.
• A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
• Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Subjects With Chronic Kidney Disease
• Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease
• A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.
• A Study to Assess the Relative Bioavailability of 3 Different Formulations Under Fasted and Fed Condition
• Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
• Desidustat in the Treatment of Anemia in CKD
• Apixaban in Subjects With Peritoneal Dialysis
• Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease
• Oral Iron in Children With Chronic Kidney Disease
• A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia
• Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
• L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
• A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease
• Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
• A Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
• The Effect of Etelcalcetide on CKD-MBD
• Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
• Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial
• Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
• Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With NDD-CKD
• Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis
• Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR.
• A Study With RBT-1, in Healthy Volunteers and Subjects With Stage 3-4 Chronic Kidney Disease
• Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease
• A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects
• Metformin as RenoProtector of Progressive Kidney Disease
• A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
• Mechanisms of EPO-induced Hypertension
• Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
• Aspirin to Target Arterial Events in Chronic Kidney Disease
• Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
• RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD
• Role of AST120 for Sarcopenia Prevention in Pre-dialysis Chronic Kidney Disease
• Renoprotective Effects of Telbivudine in Chronic Hepatitis B
• Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
• Observation on the Effect of Sacubitril/Valsartan in Advanced Chronic Kidney Disease（CKD）Patients With Heart Failure
• An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)
• Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?
• Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
• Effect of Vitamin D Supplementation on Balance in CKD
• Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
• Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)
• Chronic Kidney Disease (CKD) Platelet Study
• PA21 Safety and Efficacy in Adult Chinese Subjects
• RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteine
• Management of Cardiovascular Disease in Kidney Disease (MaCK) Study
• Study of Etelcalceide in Pediatric Subjects With Secondary Hyperparathyroidism and CKD on Hemodialysis
• A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
• A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
• The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD
• Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern
• Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
• The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
• Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney D
• Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients With Chronic Kidney Disease
• Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation
• Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation
• Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease
• Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects.
• Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V
• Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
• HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
• The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
• Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population
• Maintenance Treatment of Renal Anemia in Dialysis Subjects
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
• To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)
• Safety and Efficacy of Two Year Spnol and Maximal R Blockad Therapy
• Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
• Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients
• Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
• Blood Pressure Lowering in Dialysis (BOLD) Trial
• Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)
• Different Effects of Non-calcium Phosphate Binders on Serum Calcium
• Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)
• Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
• the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD
• Effect of Hyperuricaemia on Chronic Renal Disease
• A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
• Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
• Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
• A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
• Removal of Beta Blocker Drugs by Hemodialysis
• TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
• A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects
• A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects
• A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects
• Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
• Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease
• Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells
• Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
• Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)
• A Clinical Trial to Evaluate Safety and Efficacy of a Renal Denervation System in Treatment of Hypertension
• Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
• Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
• Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
• A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control
• KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
• A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
• Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney Disease
• Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects
• Hyperphosphatemia in Children With Chronic Kidney Disease
• Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension
• Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
• A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
• Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria
• Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.
• Mitochondria and Chronic Kidney Disease
• A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein
• A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis
• Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
• A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir
• Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease
• Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents
• A Study of Patients With Chronic Kidney Disease to Assess the Safety of a Single Dose of COR-001
• Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement
• A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease
• Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria
• Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
• The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients
• EMPRA (EMPagliflozin and RAs in Kidney Disease)
• Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients
• Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease
• Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
• Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease
• Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease
• Ferric Citrate in ESRD Pilot Project
• Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
• Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105
• A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
• Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
• Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
• The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum
• Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
• Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
• Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
• A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia
• A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
• Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
• Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)
• Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)
• A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
• A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia
• Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes
• LMWH Infusion as Anticoagulation for Home HD
• Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide
• A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia
• Neurovascular Transduction During Exercise in Chronic Kidney Disease
• Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C
• Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients
• Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
• Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
• Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease
• Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
• Bicarbonate Administration in CKD
• Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis
• HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant
• Efficacity and Safety of Metformin XR in CKD Stage 1 to 3
• Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-dependent Chronic Kidney Disease (DD-CKD)
• Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
• Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease
• The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)
• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
• DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
• Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.
• Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
• Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
• Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver
• Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
• Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study
• Senescence in Chronic Kidney Disease
• Chlorthalidone in Chronic Kidney Disease
• Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease
• A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis
• Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents
• Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients
• Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery
• Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis
• Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes
• Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency
• Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)
• Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease
• Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis
• Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial)
• Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease
• Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease
• Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia
• Periodic Versus Continuous IV Iron Supplementation in HD Patients
• A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia
• A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia
• A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) Treatment
• Propolis Effects in Patients With Chronic Kidney Disease
• Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
• A Trial of Doxycycline in Renal Disease
• Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients
• Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease
• Remission Clinic in Proteinuric Chronic Nephropathies
• Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-sti
• Contrast-enhanced Ultrasound of the Kidney
• Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure.
• A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure
• Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
• Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function
• Apixaban in Hemodialysis
• Determining Oral Phosphate Tolerance Across the Spectrum of Glomerular Filtration Rate
• Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus
• FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis
• FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease
• Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
• Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension
• A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
• Comparison of Effectiveness and Safety of Three Lock Solutions for Long-Term Central Venous Catheter for Hemodialysis
• A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management
• A Study of LY3113593 in Participants With Chronic Kidney Disease
• Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults
• Severe Sepsis in Children - IMPRESS-C
• Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis
• Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis
• Diuretic/Cool Dialysate Trial
• Effect of Sodium Rinsing Fluid on Blood Pressure and Interdialytic Weight Change in Hemodialysis Patients
• Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
• CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
• COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS
• Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study
• Montelukast for Treatment of Uremic Pruritus
• A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis
• Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial
• An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)
• Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease
• Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease
• Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery
• The BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR)
• Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
• A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Dis
• Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure
• Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan
• Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients
• A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
• Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)
• Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
• Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
• Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
• Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
• Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
• Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease
• TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
• Helping Olfaction and Nutrition On Renal Replacement
• Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
• Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation
• Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol
• Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients
• Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis
• Glargine Versus NPH in Patients With Chronic Kidney Disease
• Acid-Base Compensation in Chronic Kidney Disease
• Optimising Renal Outcome in Myeloma Renal Failure
• Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease
• A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
• Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula
• Sympatholysis in Chronic Kidney Disease
• Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease
• The Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment (RoSIE)
• Ticagrelor and Anti-inflammatory Effects
• Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis
• An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Diseas
• Genotype and Platelet Reactivity in Patients on Hemodialysis
• Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.
• Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
• The Lighthouse Tenofovir Cohort Study
• Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
• A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
• A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease
• Rifaximin Therapy in Chronic Kidney Disease
• Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'
• Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis
• Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis
• Compare the Renal Protective Effects of Febuxostat and Benzbromarone
• Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
• A Phase 2 Extension of Study GCS-100-CS-4003
• A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
• A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting
• Vitamin K Supplementation in Patients on Hemodialysis
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
• The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study
• To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects
• A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
• A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency
• Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease
• Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease
• Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study
• A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis
• Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
• Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
• Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002
• Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis
• Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4
• KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
• Hypoxia and Inflammatory Injury in Human Renovascular Hypertension
• An Observational, Prospective, Safety Study of Mircera (Monopegylated Epoetin Beta) in Clinical Practice
• 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Subjects With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
• The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
• Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
• Metformin in Kidney Disease
• Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
• Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.
• Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis
• Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
• Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
• Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria
• Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
• An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD
• Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease
• Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease
• Phophate Lowering Trial
• Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
• Effect of Sevelamer on P-cresol Levels in CKD
• Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients
• Chinese Medicine on Deferring Dialysis Initiation
• Residual Renal Function Preservation in Peritoneal Dialysis Patients
• Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis
• ONSET and OFFSET of Ticagrelor in ESRD
• Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
• A Phase 2 Extension Study of Study GCS-100-CS-4002
• Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
• A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis
• Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis
• A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects
• The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
• A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia
• Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant
• Boceprevir in End Stage Renal Disease (ESRD)
• A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)
• Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis
• Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052)
• Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
• Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
• Long-term Pre-dialysis Extension in Europe and Asia Pacific
• Comparison Among Erythropoietin Stimulating Agents
• Zibotentan Better Renal Scleroderma Outcome Study
• Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)
• Metabolic Acidosis and Vascular Function in Patients With Chronic Kidney Disease
• Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules
• Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934
• 15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
• Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa
• Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract
• Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease
• Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis
• Molecular MRI of the Fibrotic Heart
• Evaluating the Effect of Senna in Uremic Pruritus
• Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition
• Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites
• Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET)
• Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.
• A Study of LY2928057 in Hemodialysis Participants
• Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients
• Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease
• A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
• ISCHEMIA-Chronic Kidney Disease Trial
• Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease
• A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
• Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia
• Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function
• Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects
• Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
• Supplementation With Cholecalciferol in Dialysis Patients
• Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease
• Sevelamer in Proteinuric CKD
• ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-
• Once-a-day Immunosuppression(CISECON_a_day)
• Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting
• Fosrenol Post-marketing Surveillance in Japan
• Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Diseas
• Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
• Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease
• Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients
• An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis
• A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking Rifampin
• A Study of LY2409021 in Participants With Different Levels of Kidney Function
• Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders
• Role of Turmeric on Oxidative Modulation in ESRD Patients
• 20-Week Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
• Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis
• Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet
• Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
• Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease
• A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study)
• Study of South African Dialysis Patients
• A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
• Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis
• A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
• PK of Serelaxin in Severe Renal Impairment and ESRD
• Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis
• CSPPT- Chronic Kidney Diseases Study
• Endovenous Versus Liposomal Iron in CKD
• Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula
• Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia
• L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD
• ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial
• A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
• An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction
• A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
• Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery
• EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety
• Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease
• RAS Quantification in Patients With Aliskiren or Candesartan
• Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD
• Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients
• N-Acetyl Cystein and Contrast Nephropathy
• Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)
• Safety and Tolerability Study of MCI-196
• Kidney Graft Function Under the Immunosuppression Strategies
• Long-term Extension Study of MCI-196
• Dose-finding Study of MCI-196
• A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)
• Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chroni
• Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease
• Kidney and Periodontal Disease Study
• Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease
• Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
• Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
• Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis
• Renal Allograft Tolerance Through Mixed Chimerism
• Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
• Paricalcitol Effect on Anemia in CKD
• Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis
• The Role of Peritoneal Dialysis in Patients With Refractory Heart Failure and Chronic Kidney Disease
• A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)
• A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD
• A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis
• Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol
• Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
• A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
• Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis
• Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension
• Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
• Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis
• A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)
• Safety Study of GCS-100 to Treat Chronic Kidney Disease
• Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.
• Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal Disease
• Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
• Qutenza for Critical Ischaemia in End Stage Renal Failure
• Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
• FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients
• A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
• A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on
• Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.
• Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
• Mineralocorticoid Receptor Antagonists in End Stage Renal Disease
• Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
• Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.
• Paricalcitol and Endothelial Function in Chronic Kidney Disease Patients (the PENNY Study)
• Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)
• Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD Patients
• Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
• Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
• Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
• A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
• Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
• Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency
• Hyperglycemia in Renal Transplantation
• Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease Patients
• Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder
• Renal Transplantation in the Elderly - nEverOld Study
• Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease
• Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology
• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
• Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes
• Study of Everolimus in de Novo Renal Transplant Recipients
• Study of FG-4592 in Subjects With Chronic Kidney Disease in China
• Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China
• A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation
• Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease
• Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)
• 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease
• 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
• Fosrenol and Phosphorus Balance - Lanthanum Carbonate
• PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease
• A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
• HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)
• Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism
• A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
• An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease
• Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.
• A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
• Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects
• Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor
• Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
• Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia
• Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
• A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
• Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
• The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria
• Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study
• A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
• Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients
• Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease
• Vitamin D Metabolism in Chronic Kidney Disease Patients
• PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia
• A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis
• A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients
• A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease
• Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis
• Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis
• A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
• A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
• Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome
• Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment
• Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)
• Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
• Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil
• Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)
• Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
• A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.
• A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
• Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease
• Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)
• Renal Transplantation and Raltegravir in HIV-Infected Patients
• Alkali Therapy in Chronic Kidney Disease
• Safety and Dialysability of Dotarem® in Dialysed Patients
• Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients
• Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
• Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease
• A Study of LY2623091 in Male and Females With Chronic Kidney Disease
• Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
• Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
• Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan
• Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder
• A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)
• Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients
• A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy
• Steroids and Azathioprine in Advanced IgAN
• Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast Agent
• Vitamin D and Arterial Function in Patients With Chronic Kidney Disease
• A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
• 42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
• Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)
• Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients
• Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
• Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
• Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age
• Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease
• Prevention of Contrast Induced Nephropathy by Erythropoietin
• Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease
• Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction
• Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled D
• Low Molecular Weight Heparin for Hemodialysis Anticoagulation
• Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients
• Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease
• BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease
• Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
• Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
• Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease
• Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging
• Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease
• Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
• A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients
• A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512)
• Measurement of Kidney Blood Flow and Oxygen Levels by MRI
• Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease
• A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
• Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients
• Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients
• Effect of Adipokines in Hemodialysis Patients
• Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients
• Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients
• Pediatric Chronic Kidney Disease Safety and Efficacy
• Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4
• Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
• Effects of Ergocalciferol on Erythropoetin Stimulating Agent Dose
• Atorvastatin and Sympathetic Activity in Chronic Kidney Disease
• Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
• Effect of N-acetylcysteine on Renal Functioning of Chronic Kidney Diseases(CKD) Patients After General Anesthesia
• Acute Effects of Cinacalcet on Arterial Stiffness and Ventricular Function in Hemodialysis Patients
• Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease
• Study of FG-4592 in Non-Dialysis Chronic Kidney Disease Patients With Anemia
• Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance
• Safety and Efficacy Study for AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
• Bosutinib In Subjects With Renal Impairment
• Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
• Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
• Safety and Dose Finding Study of Xigris in Hemodialysis Patients
• A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D
• Impact of Vitamin D Therapies on Chronic Kidney Disease
• FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease
• Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
• Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)
• Influence of Aliskiren on Proteinuria
• Nasal Tea Tree Oil for the Prevention of Infections in PD Patients
• Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD
• Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
• Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease
• Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
• A Study in Participants With End-Stage Renal Disease
• Effect of Darbepoetin in Contrast-induced Nephropathy
• A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)
• Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
• Long-term Study in Chronic Kidney Disease (Extension From Study 14817)
• Impact of Vitamin D Repletion in Hemodialysis Patients
• Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
• A Pilot Study for PK/PD Parameter of Colchicine in Chronic Kidney Disease Patient.
• A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment
• The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease
• The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate
• The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
• Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
• Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease
• Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis
• Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease
• Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice
• Comparison of the Protective Effect of Desflurane and Propofol in Patients With Renal Transplantation
• Effect of Lanthanum Carbonate in Patients Previously Treated With Calcium-based Phosphate Binder Therapy
• Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease
• Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD
• MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5
• Study of Erythropoietin (EPO) Administration Schedule
• Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
• Study in Chronic Kidney Disease (CKD) Not on Dialysis
• Pilot Study of Velcade® in IgA Nephropathy
• Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study)
• Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
• A Safety Study of Pentoxifylline for the Treatment of Anemia
• Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients
• Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients
• Trial to Optimize Mineral Outcomes in Dialysis Patients
• Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function
• RenalGuard System and Contrast Media
• Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
• Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients
• TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
• Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers
• Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoing Haemodialysis
• A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
• Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease
• Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients
• Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery
• Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.
• Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
• A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
• Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
• A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
• Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease
• Effect of Turmeric on Pruritus in Hemodialysis Patients
• A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
• The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
• hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease
• Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy
• Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)
• A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
• Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease
• Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
• Metabolic Effects of Paricalcitol
• The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
• A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease
• The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney Disease
• FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease
• N-acetyl-cysteine (NAC) and Kidney Graft Function
• Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemo
• Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
• Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism
• The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure
• Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D
• Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
• Vitamin D and Chronic Renal Insufficiency
• A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)
• Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
• Observational Prospective Study on Patients Treated With Norditropin®
• Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
• Chronic Kidney Disease Antidepressant Sertraline Trial
• Evaluation of New Markers to Assess Kidney Function
• Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
• Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease
• A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)
• A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients
• A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
• Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus Placebo
• Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)
• A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy
• Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interleukin-1 Receptor Antagonist (IL-1ra)
• Study of Vitamin D3 Supplementation in Patients With Chronic Kidney Disease
• Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria
• Sympathetic Nerve Activity in Renal Failure
• Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
• DIVINE: Dialysis Infection and Vitamin D In New England
• Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose
• Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation
• Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients
• Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects
• Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects
• Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease
• Study to Evaluate Daptomycin Given During Dialysis and After Dialysis
• Vitamin D, Chronic Kidney Disease (CKD) and the Microcirculation
• Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults
• Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease
• Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)
• Kremezin Study Against Renal Disease Progression in Korea
• Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis
• The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria
• Study of Safety and Efficacy on New Peritoneal Dialysis Solutions
• Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
• Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis
• Niacin and Endothelial Function in Early CKD
• Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease
• Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease
• Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
• Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)
• A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis
• A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
• Study of Phosphate Levels in Patients With Chronic Kidney Disease
• Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide
• Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
• Sitaxsentan in Proteinuric Chronic Kidney Disease
• Calcineurin Free Immunosuppression in Renal Transplant Recipients
• Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
• Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects
• Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
• Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation
• Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
• Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease
• Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compa
• 20070360 Incident Dialysis
• Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive
• Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients
• Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease
• Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)
• Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes
• A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
• Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients
• Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism
• A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Ery
• Vitamin D Repletion in Chronic Kidney Disease
• Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
• Study of Atorvastatin Dose Dependent Reduction of Proteinuria
• The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
• Phase 2 Study of FG-4592 in Subjects With Anemia and Chronic Kidney Disease Not Requiring Dialysis
• Vitamin D and Coronary Calcification Study
• A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis
• Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients
• Sevelamer Hydrochloride in Peritoneal Dialysis Patients
• Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus
• Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity
• Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
• Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment
• A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis
• Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis
• Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange
• Endothelin Receptor Antagonism in Proteinuric Nephropathy
• Aliskiren and Muscle Sympathetic Nerve Activity
• A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.
• Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation
• Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis
• Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure
• Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
• Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis
• Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis
• Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)
• Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
• Queen's University Investigation of Calcification in Chronic Kidney Disease
• An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis
• Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA
• 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease
• A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients
• Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
• Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis
• A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)
• Paricalcitol Injection Phase II Trial
• A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis
• Testosterone Replacement Therapy in Advanced Chronic Kidney Disease
• A Study of Subcutaneous Mircera for the Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
• A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease
• Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.
• Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency
• A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis
• Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria
• The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
• Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
• Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients
• Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
• Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
• A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function
• Oral Paricalcitol in Kidney Transplant Recipients
• Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function
• A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant
• Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease
• Optimalization of Nephroprotection Using N-Acetylcysteine
• Optimalization of Nephroprotection Using Atorvastatin (Sortis)
• Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
• A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
• Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients
• Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients
• A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis
• Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
• Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients
• Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis
• A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
• A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia
• A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients
• Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
• Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
• NESP Pediatric Study
• Effects of Mesna on Homocysteine in Kidney Failure
• Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
• Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
• Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease
• Lipid Infusion in Dialysis Patients With Endotoxemia
• A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
• A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
• The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis
• Vitamin D and Carboxy PTH Fragments in Coronary Calcification
• A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)
• A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)
• The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
• The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4
• A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.
• Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)
• Fall Prevention by Alfacalcidol and Training
• Follow-up Study to Previous CARE Trial
• Loop Diuretics in Chronic Kidney Disease
• Treatment of Secondary Hyperparathyroidism in the Uremic Patient
• A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease.
• Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate
• Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)
• Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
• Rosiglitazone and Insulin Resistance in Renally Impaired Patients
• A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
• Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients
• A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
• A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
• Head to Head Study Against Sevelamer Hydrochloride
• Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate
• An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease
• PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients
• Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease
• A Study of NeoRecormon in Patients With Chronic Kidney Disease.
• Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis
• Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
• Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis
• The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis Patients
• A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)
• Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation
• Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects
• A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
• The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors
• Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients
• A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
• Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
• Oxidative Stress and Hemodialysis Access Failure
• Evaluation of Colecalciferol Substitution in Dialysis Patients
• Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease
• Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients
• Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)
• Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease
• Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) Study
• A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis
• ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
• Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD
• STAAR-1 Clinical Study
• STAAR-3 Clinical Study
• STAAR-2 Clinical Study
• Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease
• MMF After Pediatric Liver Transplantation
• Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney Disease
• STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients
• Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia
• Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome
• Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide
• E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
• Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention
• A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa)
• Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
• EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure
• A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.
• Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)
• Spironolactone Safety in Dialysis Patients
• Dialysis Clinical Outcomes Revisited (DCOR) Trial
• Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing
• VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
• Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
• Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease
• Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency
• Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)
• Changes in Iron Markers Following Iron Loading in Hemodialysis Patients
• A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)
• Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
• Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
• Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients
• NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels
• Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
• Benazepril for Advanced Chronic Renal Insufficiency
• Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis
• Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients
• A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
• The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
• Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis
• Safety and Efficacy of Iron Sucrose in Children
• Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia
• Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
• Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease
• Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
• Peginesatide for Anemia in Chronic Hemodialysis Patients
• Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents
• MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application
• Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients
• A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.
• A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
• EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)
• A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
• Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.
• Intravenous Iron in Patients With Anemia of Chronic Kidney Disease
• Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis
• Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease
• Effect of Cytokines on Growth of Children With Chronic Kidney Failure
• Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
• A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
• Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.
• Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
• Active Vitamin D Effect on Left Ventricular Hypertrophy
• Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease
• Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease
• Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters
• Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)
• EPO Deep Tank in Dialysis Subjects
• Efficacy of Pentoxifylline on Chronic Kidney Disease
• Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis
• Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
• START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism
• Study of Heart and Renal Protection
• Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure
• An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)
• Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism
• Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease
• To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy
• Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis
• SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
• Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis
• Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels
• Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)
• Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis
• Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis
• Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis
• Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)
• A Research Study for Patients With End-Stage Renal Disease (ESRD)
• Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
• Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
• Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
• An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)
• Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
• Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease
• Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis
• Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
• Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis
• A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
• Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
• Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
• Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis
• Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)
• Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
• Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
• Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients
• A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
• Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis
• Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
• Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis